Davita Inc vs Union Pacific Corporation — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while Union Pacific Corporation trades at $277.88 (market cap $165.27B). The key difference: Union Pacific Corporation is far larger — about 14.6× Davita Inc's market cap, and Union Pacific Corporation pays a 2.04% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Union Pacific Corporation for 105 Days on average.
| DVA | UNP | |
|---|---|---|
Market Cap | $11.29B | $165.27B |
Volume | 582,204 | 1,474,117 |
Sector | Health | Industrials |
52-Week High | $240.96 | $310.62 |
52-Week Low | $103.87 | $216.37 |
Typical Hold Time | 113 Days | 105 Days |
Enterprise Value | $24.01B | $194.33B |
Dividend Yield | — | 2.04% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
Union Pacific (UNP) trades at $274.68, down 0.7% today, with a bearish technical signal despite strong Q2 2026 earnings beat. The stock shows robust fundamentals with 28.85% net margin and 39.7% ROE, supported by $9.3B operating cash flow in 2025. Recent news highlights battery-electric locomotive deployment and momentum in the Norfolk Southern combination, while analyst consensus remains bullish with a $332.10 price target.
UNP presents a compelling long-term investment with strong profitability and dividend growth, though near-term technical weakness and merger uncertainty pose risks. The stock trades at a discount to analyst targets, offering potential upside if operational execution continues and the Norfolk Southern deal progresses favorably.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.
Read more on UNP →